Observational Study of Blinatumomab
NCT03117621
·
clinicaltrials.gov ↗
COMPLETED
Status
279
Enrollment
INDUSTRY
Sponsor class
Conditions
Blincyto Use in Routine Clinical Practice
Sponsor
Amgen